Skip to main content

AGC Pharma Chemicals Europe has completed the investment of the in-house micronization facility which will broaden its service level for customers.

With a feed capacity of 30kg/h (max 50kg/h), the state-of-the-art unit has been designed to handle a wide range of API including HAPI compounds with OEB 4 (OEL band 1-10µg/m3).

The micronizer equipment is a Hosokawa Alpine Multi-Mill, with a dual system which enables wider applications.

The project denominated “Implementation of a new micronization technology for the expansion and diversification of the site capacity” (file nº: ACE002/20/000031) was partially financed by funds from ACCIÓ – Catalonia Trade & Investment of the Generalitat de Catalunya.

The new capability will provide higher flexibility and will offer our customers a complete process integration for their projects.

Contact us for more information.

Latest News

All of ArticlesCDMO ProcessesHPAPIs: The High-Potency Active Pharmaceutical Ingredients That Are Reshaping Pharmaceutical Manufacturing
2nd February 2026

HPAPIs: The High-Potency Active Pharmaceutical Ingredients That Are Reshaping Pharmaceutical Manufacturing

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.
NoticiasAGC Pharma Chemicals, once again recognized as a Top Employer
15th January 2026

AGC Pharma Chemicals, once again recognized as a Top Employer

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.
AGC PharmaAll of ArticlesCDMO ProcessesThe Key Role of Project Management in a CDMO
11th December 2025

The Key Role of Project Management in a CDMO

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.